MILLER MICHAEL PATRICK 4
4 · BioXcel Therapeutics, Inc. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
MILLER MICHAEL PATRICK
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01+30,000→ 30,000 totalExercise: $14.27Exp: 2032-07-01→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in three substantially equal annual installments following the date of grant, subject to the Reporting Person's continued service through each vesting date.